Health Condition 1: M542- Cervicalgia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients suffering from chronic neck pain for 3 months or more. 2. Age between 10 and 65 years 3. Patients of either sex, including transgender 4. Literate patients; ability to read English, Bengali or Hindi and illiterate people will be interviewed by the investigators maintaining adequate privacy to fill up the scales or questionnaires 5. Willing to take part in the study and give written informed assent and/or consent voluntarily
Exclusion criteria
Exclusion criteria: 1. Patients with known cervical radiculopathy (using spurling test) or having any severe pathological conditions causing neck pain. (e.g., cervical spondylosis, kyphosis, scoliosis, history of spinal injury, disc prolapse etc.) 2. Patients suffering from autoimmune disorders that impacts the musculoskeletal system (e.g., lupus, rheumatoid arthritis, ankylosing spondylitis) 3. Patients who are undergoing treatment with NSAIDs during 6 weeks prior to enrolment in the study. 4. Patients having history of any degenerative muscular or neurological condition that can impact the outcome measure (e.g., Parkinsonâ??s disease, amyotrophic lateral sclerosis, multiple sclerosis, different myelopathy, muscular dystrophy, etc.) 5. Patients taking spinal corticosteroid injection within 6 months. 6. Patients suffering from active or chronic, systemic, or local infection or disease. 7. The chronic neck pain is due to any invasive malignant disease/neoplasia. 8. Vulnerable population - unconscious, non-ambulatory, too ill for consultation, differently abled, terminally ill or critically ill patients, institutionalized persons, mentally disabled people. 9. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness or serious illness (like cardiac disease) affecting the quality of life or organ failure. 10. Pregnant and postpartum women, lactation. 11. Patients with the habit of tobacco chewing and/or smoking, alcoholism and/or any other forms of substance abuse and/or dependence. 12. Self-reported immune-compromised condition. 13. Already been in homeopathic treatment for any chronic illness for the last 6 months. 14. Simultaneous participation in any other clinical trial
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| EQ-5D-5L questionnaireTimepoint: At baseline, every month, up to 3 months;EQ-5D-5L VASTimepoint: At baseline, every month, up to 3 months | — |
Primary
| Measure | Time frame |
|---|---|
| Pain Detect Questionnaire (PDQ)Timepoint: At baseline, every month, up to 3 months | — |
Countries
India
Contacts
The Calcutta Homoeopathic Medical College and Hospital